Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06457698

Temporomandibular Bioviscosuplementation (Platelet-Rich Plasma Combined With Hyaluronic Acid) After Double-Puncture Arthrocentesis: a Randomized Controlled Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Instituto Portugues da Face · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Intra-articular injections of hyaluronic acid (HA) or platelet-rich plasma (PRP) have been used with temporomandibular joint (TMJ) arthrocentesis to improve lubricative properties and influence regenerative processes. A randomized, controlled clinical trial investigated the benefits of complementary bioviscosuplementation (HA+PRP) in patients submitted to double-portal TMJ arthrocentesis.

Conditions

Interventions

TypeNameDescription
PROCEDUREDouble-puncture TMJ arthrocentesis under local anaesthesiaThe first puncture involved carefully palpating the lateral rim of the glenoid fossa. A 5-cc syringe was prepared with a mixture of 3 cc of Ringer lactate and 1.8 cc of lidocaine with epinephrine. A 21-G needle connected to the syringe was gently inserted into the TMJ skin area. Once the needle tip made contact with the posterior slope of the eminence of the upper joint compartment, it was oriented vertically to access the upper compartment, allowing the surgeon to perform a validation step. For the second puncture, the joint was maintained at maximum distention with continuous inflow through the first portal, while the surgeon felt insufflation/distention in the anterior joint area. The second portal was established using a 21-G needle with successful fluid outflow. After completing an effective circuit, joint washing was carried out using intra-articular hydraulic pressure with at least 150 ml of Ringer lactate solution.

Timeline

Start date
2022-06-01
Primary completion
2024-06-01
Completion
2024-12-01
First posted
2024-06-13
Last updated
2024-06-13

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT06457698. Inclusion in this directory is not an endorsement.